Xtx Topco LTD Humanigen, Inc Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.76 - $3.33 $140,750 - $266,306
79,972 Added 216.67%
116,882 $207,000
Q1 2022

May 13, 2022
BUY
$1.81 - $3.97 $66,807 - $146,532
36,910 New
36,910 $111,000
Q4 2021

Feb 11, 2022
SELL
$3.66 - $8.22 $79,290 - $178,078
-21,664 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.93 - $17.83 $128,467 - $386,269
21,664 New
21,664 $128,000

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email